FDA approves Zydelig for three types of blood cancers
The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood cancers.
-
Subscribe
Subscribe via the RSS feed
The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood cancers.